Erika Vacchelli
7PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 28, 2022
A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients.Julie Le Naour, Zsofia Sztupinszki, Vincent Carbonnier
|Jan 25, 2021
A major genetic accelerator of cancer diagnosis: rs867228 in FPR1.Zsofia Sztupinszki, Julie Le Naour, Erika Vacchelli
|Dec 21, 2020
No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19.Adriana Petrazzuolo, Julie Le Naour, Erika Vacchelli
|Oct 13, 2020
A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency.Julie Le Naour, Peng Liu, Liwei Zhao
|Sep 16, 2020
Trial Watch: experimental TLR7/TLR8 agonists for oncological indications.Giorgio Frega, Qi Wu, Julie Le Naour
|Sep 16, 2020
Trial watch: IDO inhibitors in cancer therapy.Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel
Pageof 2
Frequent Collaborators
7 joint publications
Julie Le Naour
6 joint publications
Guido Kroemer
3 joint publications
Lorenzo Galluzzi
2 joint publications
Laurence Zitvogel
2 joint publications
Oliver Kepp
2 joint publications
Zsofia Sztupinszki
1 joint publications
Sandy Adjemian
1 joint publications
Giulia Cerrato
1 joint publications
Isabelle Martins
1 joint publications
Cornelia Richter
